Nuzenio

Mcrb

Mcrb news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Seres Therapeutics Inc (MCRB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:13:05 GMT MCRB Oct 2026 15.000 call (MCRB261016C00015000) stock historical prices and data – Yahoo Finance - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 03:00:22 GMT Seres Therapeutics exits more Cambridge real estate early - The Business JournalsThe Business Journals · Wed, 05 Aug 2026 21:16:00 GMT Seres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 14:41:21 GMT MCRB: Net loss of $42.2M and cash of $15.6M highlight urgent need for new funding by Q1 2027 - TradingViewTradingView · Wed, 05 Aug 2026 14:31:46 GMT Seres Therapeutics (MCRB) Q2 Revenue Surpasses Expectations Amid Clinical Progress - GuruFocusGuruFocus · Wed, 05 Aug 2026 13:03:49 GMT Seres Therapeutics Q2 net income turns positive on VOWST sale gain - TradingViewTradingView · Wed, 05 Aug 2026 11:19:30 GMT Seres Therapeutics Q2 Net Income Reaches $4.6 Million - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMT

Timeline

Fri, 07 Aug 2026 15:13:05 GMTSeres Therapeutics Inc (MCRB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Fri, 07 Aug 2026 03:00:22 GMTMCRB Oct 2026 15.000 call (MCRB261016C00015000) stock historical prices and data – Yahoo Finance - Yahoo Finance Singapore

Wed, 05 Aug 2026 21:16:00 GMTSeres Therapeutics exits more Cambridge real estate early - The Business Journals

Wed, 05 Aug 2026 14:41:21 GMTSeres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingView

Wed, 05 Aug 2026 14:31:46 GMTMCRB: Net loss of $42.2M and cash of $15.6M highlight urgent need for new funding by Q1 2027 - TradingView

Wed, 05 Aug 2026 13:03:49 GMTSeres Therapeutics (MCRB) Q2 Revenue Surpasses Expectations Amid Clinical Progress - GuruFocus

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Seres Therapeutics9 live mentions Yahoo Finance Singapore7 live mentions MCRB Aug6 live mentions Inc5 live mentions Yahoo Finance4 live mentions Yahoo Finance Yahoo4 live mentions Finance Singapore Yahoo4 live mentions Finance Singapore4 live mentions Net4 live mentions EPS4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mcrb.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.